Authors

• Niaz Ahmed (ORCID: https://orcid.org/0000-0001-7970-0146)
• Maurizio Balestrino (ORCID: https://orcid.org/0000-0002-5971-2200)
• Andrea Zini (ORCID: https://orcid.org/0000-0003-1486-4507)
• Delfina Ferrandi
• Marius Matusevicius (ORCID: https://orcid.org/0000-0002-2868-127X)
• Aleksandras Vilionskis (ORCID: https://orcid.org/0000-0002-8055-3558)
• Manuel Cappellari (ORCID: https://orcid.org/0000-0002-3534-3201)
• Viiu‐Marika Rand (ORCID: https://orcid.org/0000-0001-8059-4192)
• Malin Säflund
• Abdoreza Ghoreishi (ORCID: https://orcid.org/0000-0003-0623-7749)
• Manuela De Michele (ORCID: https://orcid.org/0000-0002-8443-9795)
• André Peeters (ORCID: https://orcid.org/0009-0002-6802-1898)

Institutions

• Zanjan University of Medical Sciences (IR)
• Cliniques Universitaires Saint-Luc (BE)
• Karolinska University Hospital (SE)
• Vilnius University (LT)
• Policlinico Umberto I (IT)
• Karolinska Institutet (SE)
• North Estonia Medical Centre (EE)
• Azienda Ospedaliera Universitaria Integrata Verona (IT)
• Istituto delle Scienze Neurologiche di Bologna (IT)
• Ospedale Policlinico San Martino (IT)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT)
• University of Genoa (IT)

Publication Details

Journal

Annals of Neurology

Published

2025-02-04

DOI

https://doi.org/10.1002/ana.27189

Citations

10

Primary Topic

Acute Ischemic Stroke Management

Type

article

Field-Weighted Citation Impact

13.54

Funders

• Biogen
• Stryker
• European Commission
• Ministero della Salute
• Kommunfullmäktige, Stockholms Stad
• Hjärt-Lungfonden
• Karolinska Institutet
• Stockholms Läns Landsting
• EVER Neuro Pharma
• Grupo Ferrer Internacional, S.A